Notice of Intent to Grant Exclusive Patent License; NanoDynamics, Inc., 29321 [E6-7730]

Download as PDF Federal Register / Vol. 71, No. 98 / Monday, May 22, 2006 / Notices U.S.C. App. 2). The Executive Session of the meeting will consist of discussions of personnel issues at the Naval Academy and internal Board of Visitors matters. Discussion of such information cannot be adequately segregated from other topics, which precludes opening the executive session of this meeting to the public. Accordingly, the Secretary of the Navy has determined in writing that the meeting shall be partially closed to the public because it will be concerned with matters listed in section 552b(c)(2), (5), (6), (7), and (9) of title 5, United States Code. Dated: May 11, 2006. Saundra K. Melancon, Paralegal Specialist, Alternate Federal Register Liaison Officer. [FR Doc. E6–7729 Filed 5–19–06; 8:45 am] evidence, if any, not later than June 6, 2006. ADDRESSES: Written objections are to be filed with the Naval Research Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375– 5320. FOR FURTHER INFORMATION CONTACT: Head, Technology Transfer Office, NRL Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375–5320, telephone 202–767–7230. Due to U.S. Postal delays, please FAX 202–404–7920, email techtran@utopia.nrl.navy.mil, or use courier delivery to expedite response. (Authority: 35 U.S.C. 207, 37 CFR part 404) Dated: May 16, 2006. Saundra K. Melancon, Paralegal Specialist, Office of the Judge Advocate General, Alternate Federal Register Liaison Officer. [FR Doc. E6–7730 Filed 5–19–06; 8:45 am] BILLING CODE 3810–FF–P DEPARTMENT OF DEFENSE BILLING CODE 3810–FF–P Department of the Navy Notice of Intent to Grant Exclusive Patent License; NanoDynamics, Inc. DEPARTMENT OF EDUCATION RIN 1865–ZA03 Department of the Navy, DoD. ACTION: Notice. cchase on PROD1PC60 with NOTICES AGENCY: SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to NanoDynamics, Inc., a revocable, nonassignable, exclusive license to practice in the field of Halloysite microtubules for the elution of biocidal, antifungal, or other antimicrobial agents for the prevention of growth of bacteria and/or mold in Building Materials in the residential, commercial, institutional, and healthcare construction products market excluding paint, stain, varnish and other finish coatings associated with structures in the United States and certain foreign countries, the Government-owned inventions described in U.S. Patent No. 5,492,696: Controlled Release Microstructures, Navy Case No. 76,896.//U.S. Patent No. 5,651,976: Controlled Release of Active Agents Using Inorganic Tubules, Navy Case No. 76,652.//U.S. Patent No. 5,705,191: Sustained Delivery of Active Compounds from Tubules, with Rational Control, Navy Case No. 77,037.//U.S. Patent No. 6,280,759: Method of Controlled Release and Controlled Release Microstructures, Navy Case No. 78,215 and any continuations, divisionals or re-issues thereof. Anyone wishing to object to the grant of this license must file written objections along with supporting DATES: VerDate Aug<31>2005 20:16 May 19, 2006 Jkt 208001 Grants for School-Based Student Drug-Testing Programs Office of Safe and Drug-Free Schools, Department of Education. ACTION: Notice of proposed priority, eligibility and application requirements, and selection criteria. AGENCY: SUMMARY: The Assistant Deputy Secretary for Safe and Drug-Free Schools proposes a priority, eligibility and application requirements, and selection criteria under the Safe and Drug-Free Schools and Communities National Programs for the School-Based Student Drug-Testing Programs grant program. The Assistant Deputy Secretary may use the priority, requirements, and selection criteria for competitions in fiscal year 2006 and later years. We take this action to focus Federal financial assistance on an identified national need. We intend for the priority, requirements, and selection criteria to contribute substantially to existing knowledge about the efficacy of mandatory random student drug testing as a means of deterring student drug use. DATES: We must receive your comments on or before June 21, 2006. ADDRESSES: Address all comments about the priority, requirements, and selection criteria to Robyn L. Disselkoen, U.S. Department of Education, 400 Maryland Avenue, SW., room 3E251, Washington, DC 20202–6450. If you prefer to send PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 29321 your comments through the Internet, use the following address: OSDFSdrugtesting@ed.gov. You must include the term ‘‘Comments on 2006 Student DrugTesting Notice’’ in the subject line of your electronic message. FOR FURTHER INFORMATION CONTACT: Robyn Disselkoen at (202) 260–3954. If you use a telecommunications device for the deaf (TDD), you may call the Federal Relay Service (FRS) at 1– 800–877–8339. Individuals with disabilities may obtain this document in an alternative format (e.g., Braille, large print, audiotape, or computer diskette) on request to the contact person listed under FOR FURTHER INFORMATION CONTACT. SUPPLEMENTARY INFORMATION: Invitation to Comment We invite you to submit comments regarding the proposed priority, requirements, and selection criteria. To ensure that your comments have maximum effect in developing the notice of final priority, eligibility and application requirements, and selection criteria, we urge you to identify clearly the specific priority, requirement, or selection criterion that each comment addresses. We invite you to assist us in complying with the specific requirements of Executive Order 12866 and its overall requirement of reducing regulatory burden that might result from the proposed priority, requirements, and selection criteria. Please let us know of any further opportunities we should take to reduce potential costs or increase potential benefits while preserving the effective and efficient administration of the program. During and after the comment period, you may inspect all public comments about the proposed priority, requirements, and selection criteria in room 3E251, 400 Maryland Avenue, SW., Washington DC, between the hours of 8:30 a.m. and 4 p.m., Washington, DC time, Monday through Friday of each week except Federal holidays. Assistance to Individuals With Disabilities in Reviewing the Rulemaking Record On request, we will supply an appropriate aid, such as a reader or print magnifier, to an individual with a disability who needs assistance to review the comments or other documents in the public rulemaking record for the proposed priority, requirements, and selection criteria. If you want to schedule an appointment E:\FR\FM\22MYN1.SGM 22MYN1

Agencies

[Federal Register Volume 71, Number 98 (Monday, May 22, 2006)]
[Notices]
[Page 29321]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7730]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent to Grant Exclusive Patent License; NanoDynamics, 
Inc.

AGENCY: Department of the Navy, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to NanoDynamics, Inc., a revocable, nonassignable, exclusive 
license to practice in the field of Halloysite microtubules for the 
elution of biocidal, antifungal, or other antimicrobial agents for the 
prevention of growth of bacteria and/or mold in Building Materials in 
the residential, commercial, institutional, and healthcare construction 
products market excluding paint, stain, varnish and other finish 
coatings associated with structures in the United States and certain 
foreign countries, the Government-owned inventions described in U.S. 
Patent No. 5,492,696: Controlled Release Microstructures, Navy Case No. 
76,896.//U.S. Patent No. 5,651,976: Controlled Release of Active Agents 
Using Inorganic Tubules, Navy Case No. 76,652.//U.S. Patent No. 
5,705,191: Sustained Delivery of Active Compounds from Tubules, with 
Rational Control, Navy Case No. 77,037.//U.S. Patent No. 6,280,759: 
Method of Controlled Release and Controlled Release Microstructures, 
Navy Case No. 78,215 and any continuations, divisionals or re-issues 
thereof.

DATES: Anyone wishing to object to the grant of this license must file 
written objections along with supporting evidence, if any, not later 
than June 6, 2006.

ADDRESSES: Written objections are to be filed with the Naval Research 
Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-
5320.

FOR FURTHER INFORMATION CONTACT: Head, Technology Transfer Office, NRL 
Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-5320, 
telephone 202-767-7230. Due to U.S. Postal delays, please FAX 202-404-
7920, e-mail techtran@utopia.nrl.navy.mil, or use courier delivery to 
expedite response.

(Authority: 35 U.S.C. 207, 37 CFR part 404)

    Dated: May 16, 2006.
Saundra K. Melancon,
Paralegal Specialist, Office of the Judge Advocate General, Alternate 
Federal Register Liaison Officer.
 [FR Doc. E6-7730 Filed 5-19-06; 8:45 am]
BILLING CODE 3810-FF-P